ADx will be present at the upcoming virtual AAIC 2020 NewsEvents ADx will be present at the upcoming virtual AAIC 2020
ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state. NewsEvents ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
ADx receives funding from Bill Gates for developing blood biomarkers News ADx receives funding from Bill Gates for developing blood biomarkers
Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry NewsPublications Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry
ADx and Fujirebio Join Forces with Biogen and Beckman Coulter to Advance Alzheimer’s Diagnostics NewsPublications ADx and Fujirebio Join Forces with Biogen and Beckman Coulter to Advance Alzheimer’s Diagnostics
